Dr. Ian Castillo leads the strategic direction, capability development and execution of the research and development activities of CNL’s Hydrogen and Tritium Directorate. This includes understanding various stakeholder needs with the government, assessing market trends and establishing a technology portfolio to leverage CNL’s decades of hydrogen isotopes experience in Canada and internationally, and uses for CNL’s unique differentiating facilities and capabilities. 

With over 17 years in many areas of the nuclear industry, Ian is recognized as an expert in deployment of innovative technologies in the areas of hydrogen production, hydrogen recombination, heavy water and tritium management, chemistry, and process engineering.